Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Forum on Immunopathological Diseases and Therapeutics
SJR: 0.309 SNIP: 0.041 CiteScore™: 0.18

ISSN Imprimer: 2151-8017
ISSN En ligne: 2151-8025

Archives: Volume 1, 2010 to Volume 7, 2016

Forum on Immunopathological Diseases and Therapeutics

DOI: 10.1615/ForumImmunDisTher.v2.i2.50
pages 137-143

Role of RKIP in Sensitizing Tumor Cells to Photodynamic Therapy

Valentina Rapozzi
Department of Medical Sciences University of Udine Udine, Italy
Kazuo Umezawa
Department of Molecular Target Medicine Screening Aichi Medical University School of Medicine, Aichi, Japan
Luigi E. Xodo
Department of Biomedical Sciences and Technologies, School of Medicine, University of Udine, Italy

RÉSUMÉ

Photodynamic therapy (PDT) combines the administration of a photosensitizer to a tumor and irradiation with nonthermal light to generate cytotoxic reactive oxygen species. The efficacy of the treatment depends on a number of factors including the properties of the photosensitizer, light dosage, and type of the target cells. In general, although PDT is an efficacious treatment modality, in some cases, the risk of recurrence is underestimated; thus, there is interest to improve the activity of PDT. We have recently focused on the photosensitizing properties of pheophorbide a (Pba), a chlorophyll derivative. At high-dose PDT (Pba > IC50), the growth of tumor cells is completely arrested by apoptosis and/or necrosis, while at low dose (Pba < IC50), the photosensitizer causes a temporary growth arrest followed by cell recovery. Because Pba/PDT stimulates, in a dose-dependent manner, the production of nitric oxide (NO) and NO is known to inhibit the NF-κB path-way, which is involved in the NF-κB/Snail/RKIP loop, we evaluated if the tumor cells can be sensitized to PDT by the NO-mediated inhibition of NF-κB and the concomitant activation of the RKIP proapoptotic gene. Our preliminary findings are presented.


Articles with similar content:

Pivotal Role of Nitric Oxide (NO) Induction by Photodynamic Therapy in Tumor Cells: Modification of the NF-κB/Snail/RKIP Survival/Anti-Apoptotic Loop
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 3
Valentina Rapozzi, Benjamin Bonavida, Luigi E. Xodo
Inhibition of Epithelial-to-Mesenchymal Transition (EMT) in Cancer by Nitric Oxide: Pivotal Roles of Nitrosylation of NF-κB, YY1 and Snail
Forum on Immunopathological Diseases and Therapeutics, Vol.3, 2012, issue 2
Stavroula Baritaki, Benjamin Bonavida
DETANONOate Is a Potent Chemo\ Radio-Sensitizing Agent in Colon and Colorectal Cancers as Assessed in In Vitro and In Vivo Established Tumor Xenografts
Forum on Immunopathological Diseases and Therapeutics, Vol.1, 2010, issue 4
Xiaohuan Gao, Sergio Huerta, Benjamin Bonavida
Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge
Critical Reviews™ in Oncogenesis, Vol.21, 2016, issue 5-6
Albert W. Girotti
Nuclear Factor-κB Signaling: A Contributor in Leukemogenesis and a Target for Pharmacological Intervention in Human Acute Myelogenous Leukemia
Critical Reviews™ in Oncogenesis, Vol.15, 2009, issue 1-2
Astrid Marta Olsnes, Elisabeth Ersvar, Oystein Bruserud, Bjorn Tore Gjertsen, Hakon Reikvam